PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Veterinary Record Case Reports0 citations

Diagnosis and medical management of canine idiopathic hypereosinophilic syndrome presenting as a solitary intestinal mass in a dog

View Full Paper
DWDanlei Samantha WangEnvoi Specialist PathologistsEMEmily MaddenEnvoi Specialist PathologistsEJEmily JonesQueensland Department of Transport and Main Roads

Key Points

  • To diagnose and manage a case of canine idiopathic hypereosinophilic syndrome presenting with an intestinal mass.
  • Case study of a 5-year-old female Border Collie cross dog
  • Initial investigations included blood tests and imaging showing eosinophilia and abdominal masses
  • Exploratory celiotomy and biopsies were performed for diagnosis and treatment.
  • The dog exhibited marked eosinophilia prior to treatment.
  • Histopathology confirmed eosinophilic inflammation leading to diagnosis.
  • Partial response was noted with prednisolone, and clinical remission was achieved after escalating the dosage.

Abstract

Summary A 5‐year‐old, female, neutered Border Collie cross dog presented with progressive borborygmus, vomiting and weight loss. Initial investigation revealed marked peripheral eosinophilia (7.62 × 10 9 /L, reference interval: 0.06–1.23), a large solitary jejunal mass, a single hepatic nodule and multiple markedly enlarged abdominal lymph nodes. An exploratory celiotomy was performed to acquire incisional biopsies of affected tissues. A diagnosis of idiopathic hypereosinophilic syndrome was made based on significant eosinophilic inflammation on histopathology of the affected structures, and exclusion of other causes of hypereosinophilia or multisystemic eosinophilic infiltration. The dog showed a strong partial response to the initial anti‐inflammatory prednisolone monotherapy (0.76 mg/kg/day) with resolution of hypereosinophilia, and clinical remission was achieved following escalation to an immunosuppressive dose (1.56 mg/kg/day). During tapering of prednisolone, the dog developed a new jejunal mass with marked eosinophilic infiltration at a different site, despite continued remission of the original lesions and absence of recurrent eosinophilia.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69faa28f04f884e66b533322https://doi.org/10.1002/vrc2.70469
Ask AI
Helpful
Bookmark
Share
View Full Paper